[Diabetic nephropathy].
Koya
Daisuke
D
Department of Medicine, Shiga University of Medical Science.
Kashiwagi
Atsunori
A
D000419:Albuminuria; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D015415:Biomarkers / Q000097:blood / Q000652:urine; D048909:Diabetes Complications; D003928:Diabetic Nephropathies / Q000145:classification / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D018752:Diet, Fat-Restricted; D018753:Diet, Protein-Restricted; D005081:Exercise Therapy; D006442:Glycated Hemoglobin / Q000031:analogs & derivatives* / Q000032:analysis; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D016540:Smoking Cessation
D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D015415:Biomarkers; D006442:Glycated Hemoglobin; C025617:glucosylated hemoglobin A